 |
| 19-Jan-10 | Downgrade |
Citigroup |
Buy → Hold |
|
|
| 14-Jan-10 | Upgrade |
Morgan Keegan |
Mkt Perform → Outperform |
|
|
| 18-Nov-09 | Initiated |
Morgan Keegan |
Mkt Perform |
|
|
| 17-Jul-09 | Reiterated |
Credit Suisse |
Neutral |
$55 → $59 |
|
| 08-Jun-09 | Downgrade |
Soleil |
Buy → Hold |
$66 → $49 |
|
| 28-May-09 | Initiated |
Avondale |
Mkt Outperform |
$59 |
|
| 26-Feb-09 | Initiated |
RBC Capital Mkts |
Outperform |
|
|
| 05-Dec-08 | Reiterated |
UBS |
Buy |
$70 → $65 |
|
| 01-Dec-08 | Reiterated |
Leerink Swann |
Outperform |
$77.50 → $60 |
|
| 03-Sep-08 | Initiated |
UBS |
Buy |
|
|
| 23-Jun-08 | Initiated |
Leerink Swann |
Outperform |
$70 |
|
| 18-Apr-08 | Upgrade |
William Blair |
Mkt Perform → Outperform |
|
|
| 08-Jan-08 | Upgrade |
Citigroup |
Hold → Buy |
|
|
| 07-Nov-07 | Initiated |
Credit Suisse |
Neutral |
$63 |
|
| 19-Oct-07 | Reiterated |
Bear Stearns |
Outperform |
$65 → $68 |
|
| 30-Mar-07 | Reiterated |
Goldman Sachs |
Buy |
$55 → $60 |
|
|
|
| 09-Feb-10 10:52AM | Germany Cancels Swine Flu Vaccines at BusinessWeek |
| 01:21AM | Cloning the Activist Masters' Portfolios at Seeking Alpha |
| 05-Feb-10 06:00PM | New Device Promises To Make Heart Surgery Easier And Safer Investor's Business Daily |
| 04:17PM | Baxter lobbying budget tops $1 million for 4Q AP |
| 09:27AM | Baxter Downgraded Zacks.com |
| 03-Feb-10 07:06AM | 3 Best Hedge Fund Healthcare Ideas at Seeking Alpha |
| 06:50AM | Home Health Care And Diagnostics Companies High Target Environment For Acquisitions According To RBC Capital Markets Expert Equity Analyst Wall Street Transcript |
| 02-Feb-10 01:11PM | Haemonetics Misses Zacks Estimate Zacks.com |
| 10:59AM | You Can't Afford This Huge Mistake at Motley Fool |
| 09:32AM | Becton Stays Neutral Zacks.com |
| 07:51AM | [$$] A Stock Generalist Gets Specific at Barrons.com |
| 05:00AM | Baxter, Becton Are Poised to Gain This Year at TheStreet.com |
| 02:40AM | Your Money with Chuck Jaffe: Dow forecaster puts money into health care, tech at MarketWatch |
| 30-Jan-10 09:20AM | New Star Analyst Rankings for BAXTER INTL INC StarMine |
| 29-Jan-10 11:24AM | UPDATE - U.S. FDA recalls Baxter hemodialysis system at Reuters |
| 10:49AM | UPDATE - U.S. FDA recalls Baxter's Aquarius hemodialysis at Reuters |
| 10:02AM | UPDATE - FDA sets recall of Baxter's Aquarius hemodialysis at Reuters |
| 09:11AM | Amazon: Analysts' Upgrades, Downgrades at TheStreet.com |
| 28-Jan-10 05:04PM | Drugmakers post higher sales but a mix on profits AP |
| 02:42PM | Baxter International Reports Increase in Q4 Earnings at Fox Business |
| 01:59PM | Baxter, Becton forecasts set bar too low-analysts at Reuters |
| 12:57PM | Baxter International Inc. Q4 2009 Earnings Call Transcript at Seeking Alpha |
| 12:17PM | Baxter Reports In Line Zacks.com |
| 11:57AM | Baxter International 4Q profit rises 1 percent AP |
| 11:25AM | UPDATE - Baxter posts higher earnings, matches Street view at Reuters |
| 08:42AM | UPDATE - Baxter posts higher earnings, matches Street view at Reuters |
| 08:31AM | Becton Surpasses Zacks Estimate Zacks.com |
| 07:22AM | UPDATE - Baxter posts higher earnings, matches Street view at Reuters |
| 07:19AM | BAXTER INTERNATIONAL INC Files SEC form 8-K, Results of Operations and Financial Condition EDGAR Online |
| 07:13AM | Baxter International net income rises at MarketWatch |
| 07:09AM | InPlay: Baxter reports EPS in-line, beats on revs; guides Q1 EPS below consensus; guides FY10 EPS in-line Briefing.com |
| 07:07AM | Q4 2009 Baxter International Inc. Earnings Release - Time Not Supplied CCBN |
| 07:00AM | Baxter Achieves Record Sales, Earnings and Cash Flow for Full-Year 2009 Business Wire |
| 27-Jan-10 12:24PM | Earnings Preview: Baxter International at Seeking Alpha |
| 25-Jan-10 10:21AM | 12 To 24 Month Payback For Hospital Investment In Radiation Oncology Equipment Creates Upside For The Stocks Of These Medical Equipment Suppliers Wall Street Transcript |
| 19-Jan-10 01:47PM | Germany Cancels Swine Flu Vaccines at BusinessWeek |
| 01:20PM | Baxter Skips Health Stock Rally As Citi Downgrades To Hold at Barrons.com |
| 09:34AM | Philip Morris: Analysts' Upgrades, Downgrades at TheStreet.com |
| 09:34AM | Philip Morris: Analyst Upgrades, Downgrades at TheStreet.com |
| 09:19AM | Citi cuts rating on Baxter to hold from buy at MarketWatch |
| 06:54AM | Baxter downgraded by Citigroup Briefing.com |
| 15-Jan-10 06:05PM | ASRT, others donate to Haiti relief at bizjournals.com |
| 08:09AM | Stock Picks: Becton, Baxter, Tyson at BusinessWeek |
| 14-Jan-10 03:51PM | JPMorgan Challenge: Do You "Heart" This Company? at Motley Fool |
| 03:00PM | Baxter International Fourth Quarter 2009 Financial Results Conference Call Business Wire |
| 10:33AM | Baxter upgraded to 'Outperform' at Morgan Keegan AP |
| 09:00AM | Heartland Health in Missouri Receives Prestigious $100,000 Foster G. McGaw Prize for Excellence in Community Service Business Wire |
| 13-Jan-10 09:45PM | [$$] European Governments Cancel Vaccine Orders at The Wall Street Journal Online |
| 05:48AM | European Governments Cancel Vaccine Orders at The Wall Street Journal Online |
| 12-Jan-10 08:02PM | Baxter International Inc. Earnings Call scheduled for Thu, Jan 28 CCBN |
| 01:56PM | [$$] A Health-Care Guru's Stock Picks for 2010 at Barrons.com |
| 11-Jan-10 06:40PM | Countries re-think swine flu vaccine orders at Reuters |
| 11:18AM | Flu Vaccine: U.S. Cuts Order, U.K. Tries to Recoup Costs at The Wall Street Journal Online |
| 06:06AM | U.S. scales back H1N1 vaccine, cuts CSL order in half at Reuters |
| 10-Jan-10 03:05PM | Move to recover cost of flu vaccine at FT.com |
| 08-Jan-10 11:48AM | UPDATE - Britain joins others in curbing flu vaccine supply at Reuters |
| 10:53AM | UK discussing flu vaccine cuts with Glaxo, Baxter at Reuters |
| 07:39AM | France cuts swine flu vaccine order from Novartis at Reuters |
| 07-Jan-10 09:05AM | Greisch tapped to head Hill-Rom at bizjournals.com |
| 06-Jan-10 04:00PM | Baxter to Present at the 28th Annual J.P. Morgan Healthcare Conference Business Wire |
| 05-Jan-10 11:59AM | FTSE closes up 0.4 pct; banks, miners gain at Reuters |
| 07:35AM | Strong banks, commods drive FTSE higher at midday at Reuters |
| 07:19AM | European stocks flat; banks up, pharmas down at Reuters |
| 06:26AM | French move fuels fears for flu vaccine sales at Reuters |
| 05:03AM | Europe stocks dip; pharmas sag on vaccine sales woes at Reuters |
| 31-Dec-09 08:25AM | Is a Weak Dollar the Best Healthcare Bet? at TheStreet.com |
| 30-Dec-09 11:45AM | Health-Care Stocks Stuck in Waiting Room at Barrons.com |
| 29-Dec-09 09:13AM | Swine Flu Vaccine News Back From the Dead Indie Research |
| 28-Dec-09 11:33AM | [video] Health Care Investing in 2010 at CNBC |
| 24-Dec-09 09:40AM | Top 10 Stocks for Obamacare at CNBC |
| 21-Dec-09 10:00AM | Farrell: The Health Care Bill & Stocks We Like at CNBC |
| 08:15AM | [$$] Standing Firm on Health Stocks Despite D.C. Deals at RealMoney by TheStreet.com |
| 18-Dec-09 06:06PM | Analyst Sees Rebound For Boston Scientific Investor's Business Daily |
| 09:24AM | UPDATE - EU drugs agency says H1N1 vaccines, Tamiflu safe at Reuters |
| 07:54AM | Pandemic flu straining Afghan health clinics - WHO at Reuters |
| 15-Dec-09 01:23PM | [$$] Baxter's Charts Show a Healthy Stock at RealMoney by TheStreet.com |
| 10:14AM | Haemonetics Files Lawsuit Zacks.com |
| 09:00AM | Baxter International Fourth Quarter 2009 Financial Results Conference Call Business Wire |
| 06:30AM | [$$] Investing Without the Help of a Rising Tide at Barrons.com |
| 14-Dec-09 05:00PM | Baxter Appoints Two Corporate Officers Business Wire |
| 10:13AM | [$$] Washington's Bungling Means Big Returns for Health Care Plays at RealMoney by TheStreet.com |
| 03:07AM | Weekly Wrap-Up: A Too-Early Bear? at Seeking Alpha |
| 11-Dec-09 12:58PM | Prospecting for Stocks: St. Jude Medical at Motley Fool |
| 10-Dec-09 03:50PM | Thursday Options Recap at Seeking Alpha |
| 10:00AM | UK study confirms H1N1 far less lethal than feared at Reuters |
| 09-Dec-09 12:24PM | H1N1 Vaccines Finally Bearing Revenue at Investopedia |
| 11:08AM | Becton Receives FDA Clearance Zacks.com |
| 10:54AM | Interview With Douglas C. Maclellan - CEO Of ADML Wall Street Transcript |
| 08:48AM | Key Stocks Do Better Under New Health Care Legislation Pending In Congress States Lazard Capital Award Winning Equity Analyst Wall Street Transcript |
| 08-Dec-09 01:03PM | Best Funds of '09: Croft Value Fund CNBC |
| 07-Dec-09 12:29PM | Insider Sales Remain High Despite Rally at Seeking Alpha |
| 10:28AM | Credit Suisse Research Analyst Explains Economic Implications Of Expansion Of Medicaid Benefits On Health Care Service Stocks Wall Street Transcript |
| 02:44AM | Two Week Wrap-Up: Trading Both Ends of Our Range at Seeking Alpha |
| 04-Dec-09 03:58PM | Baxter Receives H1N1 Vaccine Order Zacks.com |
| 03-Dec-09 10:26AM | Slovenia to buy 10,000 H1N1 vaccines from Baxter at Reuters |
| 09:36AM | RPT-UPDATE - EU: no safety concerns as 10 mln get H1N1 shots at Reuters |
| 06:35AM | EU: no safety concerns as 10 mln get H1N1 shots at Reuters |
| 29-Nov-09 12:52AM | 8 HealthCare Stocks With 3%+ Dividends at Seeking Alpha |
| 25-Nov-09 06:34PM | 10 Dividend Picks For Your Portfolio: Chief Investors at CNBC |
| 03:45PM | [video] The Dividend Strategy at CNBC |
|
|
| Baxter International Inc. develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. The company operates through three segments: BioScience, Medication Delivery, and Renal. The BioScience segment manufactures recombinant and plasma-based proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, alpha 1-antitrypsin deficiency, burns and shock, and other chronic and acute blood-related conditions; products for regenerative medicine, such as biosurgery products and technologies used in adult stem-cell therapies; and vaccines. The Medication Delivery segment manufactures intravenous solutions and administration sets; premixed drugs and drug-reconstitution systems; pre-filled vials and syringes for injectable drugs, intravenous nutrition products; infusion pumps; and inhalation anesthetics. This segment also offers products and services related to pharmacy compounding, drug formulation, and packaging technologies. The Renal segment provides products to treat end-stage renal disease and irreversible kidney failure. This segment also offers solutions and other products for peritoneal dialysis, a home-based therapy and product for hemodialysis, which is conducted in a hospital or clinic. Baxter International Inc. has collaborations with HHD LLC, DEKA Products Limited Partnership, and DEKA Research and Development Corp. for the development of a home hemodialysis machine. It markets its products to hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, clinical and medical research laboratories, and patients at home under physician supervision. The company was founded in 1931 and is headquartered in Deerfield, Illinois. |
|
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| Shapazian Carole J Uhrich | Director | Dec 07 | Option Exercise | 32.22 | 5,760 | 185,587 | 9,122 | Dec 08 04:58 PM | | Shapazian Carole J Uhrich | Director | Dec 07 | Sale | 56.14 | 5,760 | 323,366 | 3,362 | Dec 08 04:58 PM | | RIEDEL NORBERT G | Corporate Vice President | Dec 02 | Option Exercise | 34.02 | 92,500 | 3,146,425 | 128,924 | Dec 04 04:52 PM | | RIEDEL NORBERT G | Corporate Vice President | Dec 02 | Sale | 55.92 | 92,500 | 5,172,600 | 36,424 | Dec 04 04:52 PM | | GATLING JAMES M | Corporate Vice President | Nov 09 | Option Exercise | 31.45 | 36,792 | 1,157,108 | 153,712 | Nov 12 04:42 PM | | GATLING JAMES M | Corporate Vice President | Nov 09 | Sale | 56.03 | 36,792 | 2,061,473 | 134,812 | Nov 12 04:42 PM | | STALLKAMP THOMAS T | Director | Feb 12 | Option Exercise | 34.31 | 10,590 | 363,331 | 30,571 | Feb 13 05:31 PM | | STALLKAMP THOMAS T | Director | Feb 12 | Sale | 58.52 | 10,590 | 619,727 | 19,981 | Feb 13 05:31 PM | | RIEDEL NORBERT G | Corporate Vice President | Jan 27 | Option Exercise | 41.34 | 80,000 | 3,307,200 | 92,399 | Jan 28 05:33 PM | | RIEDEL NORBERT G | Corporate Vice President | Jan 27 | Sale | 58.09 | 80,000 | 4,647,200 | 38,099 | Jan 28 05:33 PM | | GREISCH JOHN J | Corporate Vice President | Jan 26 | Option Exercise | 34.69 | 125,000 | 4,335,850 | 155,419 | Jan 28 05:30 PM | | RIEDEL NORBERT G | Corporate Vice President | Jan 26 | Option Exercise | 41.34 | 22,300 | 921,882 | 60,399 | Jan 28 05:33 PM | | RIEDEL NORBERT G | Corporate Vice President | Jan 26 | Sale | 58.00 | 22,300 | 1,293,400 | 38,099 | Jan 28 05:33 PM | | GREISCH JOHN J | Corporate Vice President | Jan 26 | Sale | 57.81 | 119,000 | 6,879,390 | 90,419 | Jan 28 05:30 PM |
|
|
|
|
|
|
